Funds and ETFs Baxter International Inc.

Equities

BAX

US0718131099

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 29/05/2024 am IST 5-day change 1st Jan Change
33.85 USD -0.15% Intraday chart for Baxter International Inc. -1.74% -12.44%

ETFs positioned on Baxter International Inc.

Name Weight AuM 1st Jan change Investor Rating
0.01% 112 M€ +4.44% -
0.01% 3 M€ +7.16% -
2.69% 129 M€ +7.88% -
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
33.85 USD
Average target price
46.07 USD
Spread / Average Target
+36.09%
Consensus
  1. Stock Market
  2. Equities
  3. BAX Stock
  4. Funds and ETFs Baxter International Inc.